New drug cocktail aims to ease dual Heart-Lung condition
Disease control
Recruiting now
This study tests whether adding macitentan to the standard drug dapagliflozin improves outcomes for people with heart failure and a specific type of high blood pressure in the lungs. 64 adults in South Korea will take either the combo or dapagliflozin alone for 24 weeks. Research…
Phase: PHASE4 • Sponsor: Gachon University Gil Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC